Skip to main content
University of Wisconsin-Madison

Pharmaceutical Sciences Division receives grant from AstraZeneca to support research of Yu and de Villiers research groups

The research of Lian Yu and Mel de Villiers, Professors in the Pharmaceutical Sciences Division, will benefit from an exceptional commitment from AstraZeneca towards the school’s Pharmaceutical Sciences Graduate Program.

AstraZeneca has generously agreed to provide three years of support towards research to study the stability and stabilization of amorphous drugs. The project will build on the discovery from the Yu and de Villiers research groups that surface crystallization is a major failure mechanism for amorphous drugs and that nanometer thin coatings effectively inhibit surface crystallization.